Rights and permissions
About this article
Cite this article
Dabigatran: an alternative to warfarin despite higher cost?. Pharmacoecon. Outcomes News 619, 8 (2011). https://doi.org/10.2165/00151234-201106190-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106190-00023